 MYOS RENS Technology Inc. MYOS or the Company NASDAQ: MYOS, an advanced nutrition company and the owner of Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle, announces its results for the fiscal year ended December 31, 2019. 